Results 151 to 160 of about 2,320,248 (308)

HIV counseling and testing in publicly funded sites; annual report 1997 and 1998 [PDF]

open access: yes
Published by the Division of HIV/AIDS Prevention - Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and ...

core  

Clinical Pharmacology in Transgender Medicine: What Gaps Remain?

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Mechanistic information is limited about the effects of gender‐affirming hormone therapy and the unique factors that influence the absorption, distribution, metabolism, and excretion properties of medications across therapeutic classes for transgender people.
Lauren R. Cirrincione
wiley   +1 more source

A Highly Sensitive and Specific Rapid Lateral Flow Assay for the HIV Integrase Strand Transfer Inhibitors Bictegravir, Cabotegravir, and Dolutegravir

open access: yesAIDS Research and Treatment
Xierong Wei   +8 more
doaj   +1 more source

Family's socioeconomic and demographic factors on elements of children's dental and oral health: A scoping review

open access: yesClinical and Experimental Dental Research, EarlyView.
Abstract Background Family plays a significant role in children's dental and oral health (DOH) elements, such as children's DOH knowledge and practice, the development of children's dental fear and anxiety (DFA), children's dental visits, and children's DOH status.
Wisnu Fadila   +5 more
wiley   +1 more source

Eating Disorders in Transgender, Non‐Binary, and Gender Diverse Populations: A Meta‐Synthesis of Qualitative Findings

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Some evidence suggests that gender diverse people may be disproportionately affected by eating disorders in comparison to the general population. This review aims to further understanding of the relationship between gender identity and disordered eating/exercise, as understood by gender diverse individuals.
Kirsty Matthews   +4 more
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Mobile Wellness in the Workplace: Addressing the Global Men’s Healthcare Gap, from a World Health Organization Framework Perspective

open access: yesJournal of Epidemiology and Global Health
Stephanie Davis   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy